HOME >> MEDICINE >> NEWS
Stevens' Cattabiani helps link doctors, hospitals worldwide

HOBOKEN, N.J. -- Since 2000, a Stevens Institute of Technology Special Lecturer in Chemistry and Chemical Biology, Thomas Cattabiani, has worked to help realize the global vision of a successful New York surgeon, his longtime friend and onetime classmate in the Stevens pre-med program, Undergraduate Projects in Technology and Medicine (UPTAM). The vision enfolds the establishment of clinics and hospitals worldwide that are served by Internet links to experts in the US physicians who can, from great distances, help to train other doctors, and even advise on real-time surgical procedures, in regions where the latest in modern techniques are not commonly known.

Cattabiani has traveled specifically a number of times to Serbia, a nation recovering from years of internecine warfare as part of the former Yugoslavia. There he has helped provide telemedicine capabilities to local physicians, while his friend, Dr. S. Vincent Grasso, has imparted his expertise in laproscopic i.e., minimally invasive surgery.

"Operation Outreach" in Zrenjanin, Serbia, was inspired by the success of earlier expeditions to other regions of the world. It began with a request for support from a former graduate student of Cattabiani's, Veljko Popov, and the team of surgeons working at a charity hospital, the St. John Hospital for Special Surgical Services in Zrenjanin. During 2001-2002, Operation Outreach provided donations of badly needed medical and surgical supplies; surgical equipment and training in Minimally Invasive Surgery and Medical Informatics; installation and support of a computer LAN; Serbian language software to support a hospital database; and security protocols for Internet transfer of sensitive medical data.

Cattabiani and Grasso recently initiated a new phase in the life of the Serbian hospital, in which instead of traveling to Serbia in person they directed their colleagues in innovative procedures entirely from a remote real-time Internet facility locate
'"/>

Contact: Patrick A. Berzinski
pberzins@stevens-tech.edu
201-216-5687
Stevens Institute of Technology
22-Dec-2003


Page: 1 2 3 4 5

Related medicine news :

1. US DoE awards $4 million in funding to Stevens Center for MicroChemical Systems
2. Protein that helps skin cancer spread identified by Stanford researchers
3. Treating depression helps slow physical decline in older adults, study shows
4. Laughter helps blood vessels function better
5. Chemists synthesize molecule that helps body battle cancers, malaria
6. Medication helps alcoholics control drinking
7. Changing chemistry helps explain estrogen threat to the heart
8. An implanted nerve stimulator helps drop foot sufferers walk faster and better
9. New brochure helps explain treatment for gynecologic cancers
10. Exercise helps reduce symptoms of depression, UT Southwestern researchers find
11. Diet, exercise, stimulating environment helps old dogs learn

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stevens Cattabiani helps link doctors hospitals worldwide

(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre partner ... Virginia is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is ... husband, Dr. Cole Taylor , are avid scuba divers. "As ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
Cached News: